A Review of Therapeutic Agents Given by Convection-Enhanced Delivery for Adult Glioblastoma
Glioblastoma remains a devastating disease with a bleak prognosis despite continued research and numerous clinical trials. Convection-enhanced delivery offers researchers and clinicians a platform to bypass the blood-brain barrier and administer drugs directly to the brain parenchyma. While not with...
Saved in:
Main Authors: | Nathaniel W. Rolfe (Author), Nicholas B. Dadario (Author), Peter Canoll (Author), Jeffrey N. Bruce (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Convection Enhanced Delivery of Topotecan for Gliomas: A Single-Center Experience
by: Pavan S. Upadhyayula, et al.
Published: (2020) -
Convection Enhanced Delivery in the Setting of High-Grade Gliomas
by: Chibueze D. Nwagwu, et al.
Published: (2021) -
Effect of tissue permeability and drug diffusion anisotropy on convection-enhanced delivery
by: Wenbo Zhan, et al.
Published: (2019) -
Amphiphilic Anionic Oligomer-Stabilized Calcium Phosphate Nanoparticles with Prospects in siRNA Delivery via Convection-Enhanced Delivery
by: Franziska Mitrach, et al.
Published: (2022) -
Methylxanthines: Potential Therapeutic Agents for Glioblastoma
by: Daniel Pérez-Pérez, et al.
Published: (2019)